
Join to View Full Profile
620 S Taylor Ave# DvSaint Louis, MO 63110
Phone+1 314-362-9098
Fax+1 314-362-9851
Dr. Budge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Vanderbilt University Medical CenterFellowship, Infectious Disease, 2011 - 2014
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2007 - 2009
- Vanderbilt University School of MedicineClass of 2007
Certifications & Licensure
- MO State Medical License 2014 - 2026
- TN State Medical License 2009 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Spontaneous Antigenemia in Loiasis Start of enrollment: 2020 Jan 23
Publications & Presentations
PubMed
- Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial.Guibehi Benjamin Koudou, Catherine M Bjerum, Foungoye Allassane Ouattara, Toki Pascal Gabo, Charles W Goss
The Lancet. Infectious Diseases. 2025-10-01 - Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination.Rachel E Pietrow, Catherine Bjerum, Benjamin G Koudou, Taniawati Supali, Philip J Budge
Plos Neglected Tropical Diseases. 2025-05-01 - 1 citationsLEDoxy-SL: A Placebo-Controlled, Double-Blind, Randomized, 24-Month Trial of Six Weeks of Daily Doxycycline Plus Hygiene-Based Essential Care for Reducing Progression ...Thishan Channa Yahathugoda, Nirmitha Lalindi De Silva, Janaka Ruben, Sharmini Gunawardena, Mirani Vasanthamala Weerasooriya
The American Journal of Tropical Medicine and Hygiene. 2024-10-01
Press Mentions
- HMN 2025: How Moxidectin May Present a Quicker Path to Eliminating Parasitic an Infection Endemic to AfricaMay 8th, 2025
- Moxidectin Could Provide a Faster Route to Eliminating Parasitic Infection Endemic to AfricaMay 7th, 2025
- Accelerating the Fight Against Parasitic Infections Endemic to AfricaMay 7th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: